Amy Judd Lieberman, J.D., serves as Deputy Director, Harm Reduction Legal Project. Before joining the Network, Amy worked briefly in litigation after a fellowship with the National Health Law Program (NHeLP) working on critical issues related to the opioid epidemic and promoting harm reduction practices, specifically in the communities served by Medicaid and Medi-cal.

Amy serves on the board of directors of the Sidewalk Project Los Angeles, a drug user- and sex worker-led syringe services program serving the unhoused community in downtown Los Angeles, in addition to providing pro bono legal consultation to other SSPs through the California Syringe Exchange Program (CASEP) Coalition.

Amy received her B.F.A from New York University and her J.D. from the University of California, Irvine School of Law.  She is barred in California and the United States District Court for the Central District of California.

Articles & Resources

Healthcare Policies to Reduce Overdose and Other Drug-related Harm

WebinarsHarm Reduction Legal ProjectSubstance Use Prevention and Harm Reduction

June 6, 2024
by Amy Lieberman

The Network for Public Health Law’s Harm Reduction Legal Project, in collaboration with ChangeLab Solutions, is hosting a series of four webinars funded by the Centers for Disease Control and Prevention to introduce two forthcoming resources that policy decision makers can use to support their work to advance policies to reduce overdose and other drug-related harm. In this session – focused on the healthcare sector – a guest speaker will discuss their experience implementing harm reduction policies, including strategies and challenges, and answer questions from attendees.

View page

Criminal and Legal Policies to Reduce Overdose and Other Drug-related Harm

WebinarsHarm Reduction Legal ProjectSubstance Use Prevention and Harm Reduction

June 6, 2024
by Amy Lieberman

The Network for Public Health Law’s Harm Reduction Legal Project, in collaboration with ChangeLab Solutions, is hosting a series of four webinars funded by the Centers for Disease Control and Prevention to introduce two forthcoming resources that policy decision makers can use to support their work to advance policies to reduce overdose and other drug-related harm. In this session – focused on the criminal/legal sector – a guest speaker will discuss their experience implementing harm reduction policies, including strategies and challenges, and answer questions from attendees.

View page

Six Policies That Advance Mental Health

Policy BriefMental Health and Well-BeingMechanisms for Advancing Public HealthMechanisms for Advancing Health Equity

June 3, 2024
by Amy Lieberman, April Shaw, Ashleigh Dennis, Daniel Wacker, Darlene Huang Briggs, Emma Kaeser, Jill Krueger, Joanna S. Suder and Susan Fleurant

In recognition of Mental Health Awareness Month, Network attorneys and staff have identified six key policies with the potential to significantly improve mental health outcomes across the United States. This policy brief covers a wide range of areas focused on communities and those who work to support communities. It is designed as a practical resource for public health professionals, leaders, and partners, offering strategies to enhance mental health and well-being while reducing disparities in mental health care.

View page

Community-Based Policies to Reduce Overdose and Other Drug-related Harm

WebinarsHarm Reduction Legal ProjectSubstance Use Prevention and Harm Reduction

May 21, 2024
by Amy Lieberman

Attend this webinar, co-sponsored by the Network’s Harm Reduction Legal Project and ChangeLab Solutions, to learn about resources communities can employ to support selecting, adopting, and implementing policies to reduce overdose and other drug-related harm. Law and policy experts will provide an overview of two recently published resources: Preventing Overdose and Reducing Drug-Related Harm: A Policy Guide for State and Local Change and Implementing State and Local Overdose Prevention Policies: A Resource for Navigating the Policy Process. Attendees will also hear from individuals working within their communities to implement harm reduction strategies and policies.

View page

Harm Reduction Laws in the United States – 2024 Update

WebinarsSubstance Use Prevention and Harm Reduction

February 27, 2024
by Amy Lieberman, Ashleigh Dennis and Corey Davis

In the U.S. there is considerable variation in the presence and specifics of laws regarding drug paraphernalia, naloxone access, and protections for people who call for help in an overdose, and these laws have changed over time. This webinar is designed to reduce confusion around harm reduction laws in the U.S. and help individuals and organizations better understand how the legal landscape in their state may impact access to harm reduction services and supplies and emergency medical assistance in an overdose.

View page

Changing State Policy to Promote Stronger Opioid Antagonists: Unnecessary and Potentially Harmful

Law & Policy InsightsSubstance Use Prevention and Harm ReductionHarm Reduction Legal ProjectHarm Reduction Legal Project Resources

February 22, 2024
by Amy Lieberman

The increasing need for access to naloxone to reverse opioid-related overdoses has drawn the interest of pharmaceutical companies who see an opportunity to market new, non-generic, more potent opioid antagonist products. State lawmakers have made changes in policy based on these marketing efforts. However, early research suggests that these high dose drugs are unnecessary and pose significant risks and side-effects, raising concerns over the commercialization of harm reduction efforts in the U.S.

Read more

Naloxone Prescription Mandates

Fact SheetHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

September 11, 2023
by Amy Lieberman and Corey Davis

Drug overdose continues to claim the lives of tens of thousands of people in the U.S. every year. Opioids, both prescription painkillers and street drugs such as heroin and illicitly manufactured fentanyl, are responsible for the majority of these deaths. In response, states have passed legislation to increase access to the opioid overdose reversal medication naloxone, including provisions that allow for the distribution of naloxone through pharmacies. Some states have gone further and now require that naloxone be prescribed or offered to some patients. This fact sheet describes those requirements and links to the relevant laws.

View page

Drug-induced Homicide Laws will not Reduce Overdose Deaths: A Reminder on International Overdose Awareness Day

Law & Policy InsightsSubstance Use Prevention and Harm ReductionHarm Reduction Legal ProjectLegislation and Legal Challenges

August 30, 2023
by Amy Lieberman and Ashleigh Dennis

Over one million people in the U.S. have died from overdose since 1999. This year, as we remember those we’ve needlessly lost, we are also seeing calls for increased penalties for people who share drugs. Perhaps the cruelest form of these laws are drug-induced homicide (“DIH”) laws.

Read more

State Non-Fatal Overdose Reporting Requirements

Fact SheetHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesSubstance Use Prevention and Harm Reduction

May 30, 2023
by Amy Lieberman and Corey Davis

Variations among jurisdictions in determining and reporting causes of death and delays in obtaining and reporting fatality data often result in an incomplete and out-of-date view of the overdose epidemic in the U.S. It is imperative that health departments, harm reduction organizations, and people who use drugs are provided with accurate, timely and actionable information on drug-related overdose. This fact sheet provides a snapshot of current laws, regulations, and sub-regulatory sources governing mandatory disease reporting and a description of the laws and regulations governing reporting of overdoses in the jurisdictions that require or explicitly permit it as of March 31, 2023.

View page